Clinical Trials
New Endometrial Cancer Therapy Phase-II Trial Shows Promise
The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for patients with advanced or recurrent endometrial cancer has gone a notch up to be studied...
Clinical Trials
Duality Looks Out For Hong Kong IPO To Finance ADC Trials
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an undisclosed sum so as to power a broad pipeline when it comes to antibody conjugates...
IT & Data Management
Siemens Healthineers To Grow PET Imaging Via Novartis Assets
In a recent development taking place in the last week of August 2024, Siemens Healthineers has gone ahead and agreed to pay over 200 million euros, which is equivalent to $223 million, to purchase a part of the radiopharmaceutical...
News
Ensuring Pharmaceutical Safety With Cold Chain Strategy
Supply chain optimization for the safety of pharmaceuticals
As summertime temperatures increase, it becomes more crucial to ensure the safety of pharmaceutical items. Elevated temperatures have the potential to greatly impact the quality of products, which might have detrimental effects...
News
Global Pharma Packaging Market Set For Decade-Long Growth
Over the course of the next ten years, the global market for pharmaceutical grade plastic packaging is expected to see consistent growth.
Over the next ten years, the global market for pharmaceutical grade plastic packaging is likely to see tremendous...
News
EC approves Celltrion’s SteQeyma, a biosimilar to Stelara for the treatment of multiple chronic inflammatory diseases
The European Commission (EC) approval is based on the totality of evidence including the results from a Phase III study in adults with moderate to severe plaque psoriasis.
Celltrion today announced that the European Commission (EC) has approved the use...
News
Bisam Pharmaceuticals Unveils Quick Vitals: The World’s First AI and Deep Learning-Powered Health Monitoring App
Bisam Pharmaceuticals has launched “Quick Vitals,” the world’s first health monitoring application powered by AI and Deep Learning technologies. The launch event took place at Hotel Avasa in Hyderabad, marking a significant milestone in the intersection of technology and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.